Skip to main content

Akouos, Inc.

AKUSDelisted Dec 1, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001722271

Akouos, Inc. was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Dec 2, 2022; 64 institutions reported holding it in 13F filings for Q3 2022, worth $241.2M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
64
Q3 2022, −2 vs. previous quarter
13F value
$241.2M
Reported value at the end of Q3 2022
Superinvestors holding
0
At the end of Q3 2022

Superinvestors holding AKUS, Q3 2022

Go to the superinvestors tab

No superinvestor reported holding AKUS at the end of Q3 2022.

Latest insider trades

Open-market purchases and sales by Akouos, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 1, 2022 (view filing)4:10 PM ETNov 301 dayEli Lilly & Co and 1 other10% OwnerPPurchase+30.0M$12.50+$374.9MNew position100 after

Top 10 13F holders, Q3 2022

The largest institutional positions in Akouos, Inc. at the end of Q3 2022; share changes are against Q2 2022.

See all 64 holders
Institutions holding AKUS in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC4,582,532$31.0M0.00%−11,751−0.3%Reduced
NEA Management Company, LLC4,298,488$29.1M1.45%00.0%Unchanged
5AM Venture Management, LLC4,135,784$28.0M5.36%00.0%Unchanged
Federated Hermes, Inc.3,988,967$27.0M0.08%+607,297+18.0%Added
VR Adviser, LLC2,800,566$18.9M2.92%+133,447+5.0%Added
EcoR1 Capital, LLC1,975,984$13.4M0.39%00.0%Unchanged
Pivotal bioVenture Partners Investment Advisor LLC1,794,088$12.1M4.43%00.0%Unchanged
Sofinnova Investments, Inc.1,515,074$10.2M0.65%00.0%Unchanged
TCG Crossover Management, LLC1,350,006$9.13M2.74%00.0%Unchanged
Citadel Advisors LLC1,346,141$9.10M0.01%−31,420−2.3%Reduced